5 Antidotes to Diagnostic Uncertainty
An array of new tools, perspectives, and guidelines to help navigate the gray areas have been reported in recent days.
Patient Goals Should Figure Prominently in Tx Discussions
Wanted: Physicians who will interact with patients the way a good financial counselor would.
Prostate Cancer Treatments Abundant, Not Perfect
A range of options for metastatic castration resistant prostate cancer offer benefits, but impact on survival and sequencing guidance are less than optimal.
No Added Prostate Cancer Risk With Long-term Testosterone Tx
Risk does not go up with exposure to testosterone therapy over a 5-year period or according to total testosterone injections.
Safest for Favorable-risk Prostate Cancer: Surveillance
The goal is to avoid treating men who don’t need surgery or radiation. A new long-term study points to the potential of surveillance as a treatment option.
Paradox: Asthma Resists Lethal Prostate Cancer
Lethal prostate cancer is less—not more—likely to develop in patients with asthma. The Health Professionals Follow-up Study answers key questions about why.
Predicting Survival in Men With Prostate Cancer
Three factors may help physicians identify older men who are unlikely to benefit from aggressive therapy, and other prostate cancer news.
Commentary on the USPF's Recommendations on PSA Testing
A video series from James Mohler of Rosweel Park Cancer Institute on PSA testing in the wake of changing guidelines from the US Preventive Task Force.
Video: Who's at Risk for Prostate Cancer?
James Mohler, MD, Roswell Park Cancer Institue, discusses risk factors for prostate cancer.
Video: What To Tell Your Patients About PSA Testing
James Mohler, MD, Roswell Park Cancer Institute, defines who is at risk for prostate cancer, how to decide who should be screened, and how to talk to patients about the test and their results.